Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytotoxic Drug”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01804465
What this trial is testing

Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 50
Early research (Phase 1)Study completedNCT01923766
What this trial is testing

Cytotoxic T Cells to Prevent Virus Infections

Who this might be right for
CMVEBVAdenovirus Infections
Children's National Research Institute 10
Testing effectiveness (Phase 2)Study completedNCT02013830
What this trial is testing

Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
Hoffmann-La Roche 45
Not applicableStudy completedNCT00050063
What this trial is testing

Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 78
Early research (Phase 1)Study completedNCT01137006
What this trial is testing

An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant Melanoma

Who this might be right for
Malignant Melanoma
Eli Lilly and Company 27
Not applicableStudy completedNCT03728192
What this trial is testing

In-vitro Effect of Mangosteen Pericarp Extract on Cell Lines

Who this might be right for
Apoptosis
Meenakshi Ammal Dental College and Hospital 2
Early research (Phase 1)Ended earlyNCT00058773
What this trial is testing

Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease

Who this might be right for
Hodgkin DiseaseNon-Hodgkins Lymphoma
Baylor College of Medicine 5
Not applicableUnknownNCT02121379
What this trial is testing

Randomized Clinical Trial of 8 Weeks Pulmonary Rehabilitation in Advanced Stage Lung Cancer Patients With COPD During Cytotoxic Chemotherapy

Who this might be right for
COPDLung Cancer
Seoul National University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT03907969
What this trial is testing

A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers.

Who this might be right for
Advanced Malignancies
AstraZeneca 30
Early research (Phase 1)WithdrawnNCT05134740
What this trial is testing

(TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL).

Who this might be right for
Hodgkins LymphomaNon Hodgkins Lymphoma
Baylor College of Medicine
Early research (Phase 1)WithdrawnNCT00515957
What this trial is testing

Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)

Who this might be right for
NASOPHARYNGEAL CARCINOMA
Baylor College of Medicine
Early research (Phase 1)WithdrawnNCT03029871
What this trial is testing

Oncolytic Adenovirus-Mediated Gene Therapy for Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage I
Benjamin Movsas, M.D.
Not applicableNot Yet RecruitingNCT06857656
What this trial is testing

Knowledge, Attitudes and Practices of Safe Handling of CDs

Who this might be right for
Cytotoxic Drug
Assiut University 50
Testing effectiveness (Phase 2)Ended earlyNCT03116529
What this trial is testing

Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
University of Maryland, Baltimore 22
Testing effectiveness (Phase 2)Study completedNCT02862106
What this trial is testing

Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Chongqing Jiachen Biotechnology Ltd. 209
Not applicableUnknownNCT00489151
What this trial is testing

Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy

Who this might be right for
Hepatitis B
Hospital Authority, Hong Kong 70
Early research (Phase 1)Study completedNCT00001272
What this trial is testing

A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients

Who this might be right for
Ovarian Neoplasms
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT02900976
What this trial is testing

Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder

Who this might be right for
EBV-Related Post-Transplant Lymphoproliferative DisorderMonomorphic Post-Transplant Lymphoproliferative DisorderPolymorphic Post-Transplant Lymphoproliferative Disorder+4 more
Children's Oncology Group 18
Early research (Phase 1)Active Not RecruitingNCT02291848
What this trial is testing

Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Baylor College of Medicine 36
Early research (Phase 1)Active Not RecruitingNCT01430390
What this trial is testing

In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies

Who this might be right for
Acute Lymphocytic LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 19
Next Page